Direxion Daily Healthcare Bull 3X ETF(CURE · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$100.37
- 52-Week Range
- $66.00 – $123.80
- YTD
- -11.16%
- IV Rank (30D)
- 14.68
- Straddle Price
- $13.65
- P/C Vol Ratio
- 41.76
Info
Direxion Daily Healthcare Bull 3X ETF (CURE) ETF
- Exchange
- ARCX
- Inception
- 2011-06-15
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-08
Holdings
67
AUM
$549.1M
Provider
Direxion
Inception
2011-06-15
Exchange
ARCX
Data As Of
2026-06-08
Expense Ratio
—
Dividend Yield
1.18%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-03-24 | 2026-03-31 | $0.2832 | CD |
| 2025-12-23 | 2025-12-31 | $0.2912 | CD |
| 2025-09-23 | 2025-09-30 | $0.3101 | CD |
| 2025-06-24 | 2025-07-01 | $0.3055 | CD |
| 2025-03-25 | 2025-04-01 | $0.3455 | CD |
| 2024-12-23 | 2024-12-31 | $0.1160 | CD |
Asset Allocation
Top Holdings
top 50 of 67 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | HEALTH CARE SELECT SECTOR INDEX SWAP | 89.89% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP | 62.49% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP | 42.62% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP | 33.38% | Derivative | — |
| LLY | ELI LILLY & CO | 11.64% | Equity (US) | — |
| — | GOLDMAN FINL SQ TRSRY INST 506 | 11.07% | Derivative | — |
| — | DREYFUS GOVT CASH MAN INS | 10.49% | Derivative | — |
| — | GOLDMAN SACHS FIN GOV 465 INSTITUT | 7.91% | Derivative | — |
| JNJ | JOHNSON & JOHNSON | 7.28% | Equity (US) | — |
| ABBV | ABBVIE INC | 5.21% | Equity (US) | — |
| UNH | UNITEDHEALTH GROUP INC | 4.70% | Equity (US) | — |
| MRK | MERCK & CO. INC. | 3.89% | Equity (US) | — |
| AMGN | AMGEN INC | 2.44% | Equity (US) | — |
| TMO | THERMO FISHER SCIENTIFIC INC | 2.31% | Equity (US) | — |
| GILD | GILEAD SCIENCES INC | 2.08% | Equity (US) | — |
| ABT | ABBOTT LABORATORIES | 2.06% | Equity (US) | — |
| ISRG | INTUITIVE SURGICAL INC | 1.95% | Equity (US) | — |
| PFE | PFIZER INC | 1.92% | Equity (US) | — |
| CVS | CVS HEALTH CORP | 1.58% | Equity (US) | — |
| BMY | BRISTOL-MYERS SQUIBB CO | 1.51% | Equity (US) | — |
| DHR | DANAHER CORP | 1.50% | Equity (US) | — |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.47% | Equity (US) | — |
| SYK | STRYKER CORP | 1.37% | Equity (US) | — |
| MDT | MEDTRONIC PLC | 1.36% | Equity (US) | — |
| MCK | MCKESSON CORP | 1.23% | Equity (US) | — |
| ELV | ELEVANCE HEALTH INC | 1.19% | Equity (US) | — |
| CI | THE CIGNA GROUP | 0.99% | Equity (US) | — |
| BSX | BOSTON SCIENTIFIC CORP | 0.93% | Equity (US) | — |
| REGN | REGENERON PHARMACEUTICALS | 0.83% | Equity (US) | — |
| HCA | HCA HEALTHCARE INC | 0.76% | Equity (US) | — |
| COR | CENCORA INC | 0.69% | Equity (US) | — |
| EW | EDWARDS LIFESCIENCES CORP | 0.65% | Equity (US) | — |
| CAH | CARDINAL HEALTH INC | 0.63% | Equity (US) | — |
| IDXX | IDEXX LABORATORIES INC | 0.58% | Equity (US) | — |
| BDX | BECTON DICKINSON AND CO | 0.56% | Equity (US) | — |
| HUM | HUMANA INC | 0.55% | Equity (US) | — |
| A | AGILENT TECHNOLOGIES INC | 0.50% | Equity (US) | — |
| WAT | WATERS CORP | 0.47% | Equity (US) | — |
| ZTS | ZOETIS INC | 0.44% | Equity (US) | — |
| IQV | IQVIA HOLDINGS INC | 0.40% | Equity (US) | — |
| GEHC | GE HEALTHCARE TECHNOLOGY | 0.38% | Equity (US) | — |
| CNC | CENTENE CORP | 0.38% | Equity (US) | — |
| BIIB | BIOGEN INC | 0.37% | Equity (US) | — |
| RMD | RESMED INC | 0.37% | Equity (US) | — |
| DXCM | DEXCOM INC | 0.36% | Equity (US) | — |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 0.34% | Equity (US) | — |
| MTD | METTLER-TOLEDO INTERNATIONAL | 0.30% | Equity (US) | — |
| WST | WEST PHARMACEUTICAL SERVICES | 0.29% | Equity (US) | — |
| DGX | QUEST DIAGNOSTICS INC | 0.29% | Equity (US) | — |
| LH | LABCORP HOLDINGS INC | 0.29% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
Direxion Daily Healthcare Bull 3X Shares ·
NPORT-P period 2026-10-31
(filed 2026-04-01)
Net assets:
$165M
· 67 total positions
· equity 77.66%
· non-equity 22.20%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co. COM NPV | Eli Lilly & Co. | 11.43% | $18.9M |
| 2 | Johnson & Johnson COM USD1.00 | Johnson & Johnson | 7.60% | $12.5M |
| 3 | AbbVie Inc. COM USD0.01 | AbbVie Inc. | 5.47% | $9.0M |
| 4 | Merck & Co., Inc COM USD0.50 | Merck & Co., Inc | 3.80% | $6.3M |
| 5 | UnitedHealth Group Inc. COM USD0.01 | UnitedHealth Group Inc. | 3.61% | $6.0M |
| 6 | Thermo Fisher Scientific Inc COM USD1 | Thermo Fisher Scientific Inc | 3.02% | $5.0M |
| 7 | ABBOTT LABORATORIES | Abbott Laboratories | 2.64% | $4.4M |
| 8 | Amgen Inc. COM USD0.0001 | Amgen Inc. | 2.56% | $4.2M |
| 9 | Intuitive Surgical Inc. COM USD0.001 | Intuitive Surgical Inc. | 2.48% | $4.1M |
| 10 | Gilead Sciences, Inc. COM USD0.001 | Gilead Sciences Inc. | 2.44% | $4.0M |
| 11 | Pfizer Inc. COM USD0.05 | Pfizer Inc. | 2.09% | $3.4M |
| 12 | BOSTON SCIENTIFIC CORP | Boston Scientific Corporation | 1.92% | $3.2M |
| 13 | Danaher Corporation COM USD0.01 | Danaher Corporation | 1.91% | $3.2M |
| 14 | MEDTRONIC PLC | Medtronic PLC | 1.83% | $3.0M |
| 15 | STRYKER CORP | Stryker Corporation | 1.77% | $2.9M |
| 16 | Vertex Pharmaceuticals Incorporated COM USD0.01 | Vertex Pharmaceuticals Incorporated | 1.66% | $2.7M |
| 17 | Bristol-Myers Squibb Company COM USD0.10 | Bristol-Myers Squibb Company | 1.56% | $2.6M |
| 18 | MCKESSON CORP | Mckesson Corp. | 1.42% | $2.3M |
| 19 | CVS HEALTH CORP | CVS Health Corp | 1.31% | $2.2M |
| 20 | HCA HEALTHCARE INC | HCA Healthcare Inc | 1.08% | $1.8M |
| 21 | ELEVANCE HEALTH INC | Elevance Health Inc. | 1.07% | $1.8M |
| 22 | Regeneron Pharmaceuticals, Inc. COM USD0.001 | Regeneron Pharmaceuticals, Inc. | 1.04% | $1.7M |
| 23 | CIGNA CORP | The Cigna Group | 1.02% | $1.7M |
| 24 | AmerisourceBergen Corporation COM USD0.01 | Cencora Inc | 0.97% | $1.6M |
| 25 | BECTON DICKINSON AND CO | Becton, Dickinson and Company | 0.81% | $1.3M |
Showing top 25 of 60 equity holdings.
Non-equity holdings
— 7 positions,
22.20% of NAV
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 23.58% | $38.9M | 3 |
| Derivative (equity) | -1.38% | $-2283157 | 4 |
Daily issuer data also available
(2026-06-09)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +0.59% | 18 |
| Feb | -0.71% | 18 |
| Mar | -0.48% | 17 |
| Apr | -2.54% | 17 |
| May | +5.39% | 17 |
| Jun | +2.68% | 18 |
| Jul | +3.01% | 17 |
| Aug | +0.36% | 17 |
| Sep | -6.10% | 17 |
| Oct | +0.41% | 17 |
| Nov | +7.70% | 17 |
| Dec | -2.43% | 17 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $92.39
SMA 50: $91.01
SMA 200: $98.50
Current: $100.16
EMA 12: $95.00
EMA 26: $92.99
MACD: 2.0069 | Signal: 0.9919
BULLISH
ADX (14): 15.48
RANGE
+DI: 34.64
−DI: 19.69
Momentum Oscillators
RSI (14): 61.66
NEUTRAL
Stoch %K: 83.89
Stoch %D: 69.92
Williams %R: -23.68
Volume & Volatility
BB Upper: $101.21
BB Lower: $83.56
NEUTRAL
OBV: 1,061,563
Vol SMA 20: 103,416
Vol ROC: -53.84%
ATR: $4.18
True Range: $3.86
HV 20: 50.7%
HV 30: 47.3%
HV 60: 46.5%
Data Summary
Data Points: 500
Last Updated: 2026-06-08T21:15:20.209000
Date Range: 2024-06-10T00:00:00 – 2026-06-08T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 14.68
- IV Rank (7D)
- 48.93
- Avg IV
- 56.1%
- Straddle (30D)
- $13.65
- Straddle (7D)
- $7.30
- P/C Volume
- 41.76
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 1.32
- Correlation (SPY)
- 36.2%
- R²
- 0.13
- Ann. Volatility
- 44.2%
- SPY Volatility
- 12.1%
High volatility - stock moves more than market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|